Status:
UNKNOWN
Fluoroscopic Anterior Approach Versus Ultrasound Guided Superior Hypogastric Plexus Neurolysis in Cancer Pelvic Pain
Lead Sponsor:
Mansoura University
Conditions:
Pain Cancer
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Cancer related pelvic pain can be debilitating and difficult to treat. Superior hypogastric plexus neurolysis (SHPN) is considered to be an option for adequately relieving pain, with fewer side effect...
Detailed Description
The superior hypogastric plexus (SHP) is one of the paravertebral sympathetic ganglia, located in the lower border of the L5 vertebra and upper part of the sacrum in the retroperitoneal space. It is c...
Eligibility Criteria
Inclusion
- Patients more than 18 years old of both genders with cancer-related pelvic pain,
- poor pain control or severe side effects with opioid therapy,
- ≥ 4 on a numeric rating scale (NRS) of pain that ranged from 0 (no pain) to 10 (extreme pain).,
- American society of Anesthesiology Physical Status class I and II,
- positive diagnostic block day before the procedure by injecting a local anesthetic (0.25% bupivacaine 10 ml)
- Body mass index ˂ 30 were included in this study.
Exclusion
- patient refusal,
- local or systemic sepsis,
- coagulopathy,
- unstable cardiovascular and respiratory diseases,
- previous neurological deficits,
- history of psychiatric disorders,
- history of drug abuse,
- distorted local anatomy,
- those who were allergic to the used medications were excluded from the study.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05299047
Start Date
January 1 2022
End Date
September 1 2022
Last Update
August 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yahya Wahba
Al Mansurah, Egypt